291 related articles for article (PubMed ID: 6330154)
21. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
22. Acute effects of cocaine on prolactin and gonadotropins in female rhesus monkey during the follicular phase of the menstrual cycle.
Mello NK; Mendelson JH; Drieze J; Kelly M
J Pharmacol Exp Ther; 1990 Sep; 254(3):815-23. PubMed ID: 2118570
[TBL] [Abstract][Full Text] [Related]
23. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
24. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
Mendelson JH; Mello NK; Teoh SK; Ellingboe J
J Pharmacol Exp Ther; 1989 Sep; 250(3):902-9. PubMed ID: 2506337
[TBL] [Abstract][Full Text] [Related]
25. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle.
Seki K; Nagata I
Acta Endocrinol (Copenh); 1990 Feb; 122(2):211-6. PubMed ID: 2107654
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile secretion of gonadotropins and prolactin during the follicular and luteal phases of the menstrual cycle: analysis of instantaneous secretion rate and secretory concomitance.
Inaudi P; Reymond MJ; Rey F; Genazzani AD; Lemarchand-Béraud T
Fertil Steril; 1992 Jul; 58(1):51-9. PubMed ID: 1624023
[TBL] [Abstract][Full Text] [Related]
29. Serum follicle-stimulating hormone, luteinizing hormone, and prolactin during the induction of ovulation with exogenous gonadotropin.
Healy DL; Burger HG
J Clin Endocrinol Metab; 1983 Mar; 56(3):474-8. PubMed ID: 6401758
[TBL] [Abstract][Full Text] [Related]
30. LH and FSH responses to luteinizing releasing hormone in normal fertile women.
Wollesen F; Swerdloff RS; Odell WD
Metabolism; 1976 Nov; 25(11):1275-85. PubMed ID: 790081
[TBL] [Abstract][Full Text] [Related]
31. Sustained effects of opioid antagonism during the normal human luteal phase.
Gindoff PR; Jewelewicz R; Hembree W; Wardlaw S; Ferin M
J Clin Endocrinol Metab; 1988 May; 66(5):1000-4. PubMed ID: 3129443
[TBL] [Abstract][Full Text] [Related]
32. Naloxone does not interfere with the dopamine-induced decrease in gonadotropin secretion in women with polycystic ovarian disease.
Paradisi R; Margrini O; Venturoli S; Fabbri R; Porcu E; Stanzani L; Flamigni C
Horm Metab Res; 1985 Jan; 17(1):29-31. PubMed ID: 3917966
[TBL] [Abstract][Full Text] [Related]
33. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of gonadotrophin release in mares during the luteal phase of the oestrous cycle by endogenous opioids.
Behrens C; Aurich JE; Klug E; Naumann H; Hoppen HO
J Reprod Fertil; 1993 Jul; 98(2):509-14. PubMed ID: 8410818
[TBL] [Abstract][Full Text] [Related]
35. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
[TBL] [Abstract][Full Text] [Related]
36. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.
Filicori M; Santoro N; Merriam GR; Crowley WF
J Clin Endocrinol Metab; 1986 Jun; 62(6):1136-44. PubMed ID: 3084534
[TBL] [Abstract][Full Text] [Related]
38. Hormone ontogeny in the ovine fetus: XIV. The effect of 17 beta-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback.
Gluckman PD; Marti-Henneberg C; Kaplan SL; Grumbach MM
Endocrinology; 1983 May; 112(5):1618-23. PubMed ID: 6403330
[TBL] [Abstract][Full Text] [Related]
39. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
40. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
